Clinical value of <sup>99m</sup>Tc-MIBI scintigraphy combined with posttherapeutic <sup>131</sup>I whole-body scanning in patients with differentiated thyroid cancer with sTg ≥10 ng/mL before initial radioiodine therapy: a retrospective study. [PDF]
Han N +9 more
europepmc +1 more source
[Level of reactive oxygen species production in peripheral blood monocytes in patients with Graves' disease after radioiodine therapy]. [PDF]
Fomina DV +3 more
europepmc +1 more source
Prognostic factors in children and adolescents with differentiated thyroid cancer treated with total thyroidectomy and radioiodine therapy: a retrospective two-center study from China. [PDF]
Wang C +13 more
europepmc +1 more source
Concomitant lithium increases radioiodine uptake and absorbed doses per administered activity in graves' disease: comparison of conventional versus lithium-augmented radioiodine therapy. [PDF]
Khreish F +5 more
europepmc +1 more source
Long-Term Effects of 0.1 mg Recombinant-Human-Thyrotropin-Stimulated Fixed-Dose Radioiodine Therapy in Patients with Recurrent Multinodular Goiter after Surgery. [PDF]
Angelopoulos N +3 more
europepmc +1 more source
Unexpected 99mTc-pertechnetate avidity of lymph node metastases predicts better response to radioiodine therapy in differentiated thyroid cancer patients with lymph node metastases. [PDF]
Liu J, Li X, Li L, Yin Y, Cai H, Yi H.
europepmc +1 more source
Related searches:
Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
Endocrinology and metabolism clinics of North America (Print), 2019This article presents an overview of the use of radioactive iodine (131-I) in the treatment of patients with differentiated thyroid cancer. Topics reviewed include definitions; staging; the 2 principal methods for selection of 131-I dosage; the ...
D. Ylli, D. Van Nostrand, L. Wartofsky
semanticscholar +1 more source

